CDNA (CareDx, Inc) Stock Financials & Earnings | Market Cap Arena

CDNA (CareDx, Inc) Stock Financials & Earnings | Market Cap Arena

CDNACareDx, Inc

Mkt Cap$889M

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Revenue (TTM)$380M

Net Income (TTM)-$21M

EPS (TTM)-$0.40

Free Cash Flow (TTM)$36M

Gross Margin67.2%

Op. Margin-7.5%

Net Margin-5.6%

FCF Margin9.6%

P/S Ratio (TTM)2.3x

P/E Ratio (TTM)—

YoY Rev Growth+13.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$77M	$51M	-$24M
Q2 23	$70M	$44M	-$28M
Q3 23	$67M	$43M	-$29M
Q4 23	$66M	$40M	-$123M
Q1 24	$72M	$46M	-$19M
Q2 24	$92M	$64M	-$7M
Q3 24	$83M	$55M	-$10M
Q4 24	$87M	$58M	$75M
Q1 25	$85M	$56M	-$13M
Q2 25	$87M	$58M	-$11M
Q3 25	$100M	$69M	$2M
Q4 25	$108M	$72M	-$6M

Valuation

Quarter	P/S	P/E
Q1 23	2.8x	—
Q2 23	2.9x	—
Q3 23	3.0x	—
Q4 23	3.2x	—
Q1 24	3.2x	—
Q2 24	3.0x	—
Q3 24	2.8x	—
Q4 24	2.7x	18.0x
Q1 25	2.6x	16.0x
Q2 25	2.6x	17.2x
Q3 25	2.5x	14.6x
Q4 25	2.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$671K	-$2M
Q2 23	-$499K	-$3M
Q3 23	-$10M	-$13M
Q4 23	-$8M	-$10M
Q1 24	-$15M	-$17M
Q2 24	$19M	$17M
Q3 24	$13M	$11M
Q4 24	$22M	$20M
Q1 25	-$27M	-$28M
Q2 25	$10M	$9M
Q3 25	$37M	$36M
Q4 25	$21M	$20M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$3M
Q2 23	$2M
Q3 23	$3M
Q4 23	$2M
Q1 24	$1M
Q2 24	$2M
Q3 24	$2M
Q4 24	$2M
Q1 25	$2M
Q2 25	$1M
Q3 25	$1M
Q4 25	$2M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-2.7%	+3.2%
Q2 23	-12.8%	-4.3%
Q3 23	-15.3%	-0.7%
Q4 23	-20.4%	+85.4%
Q1 24	-6.7%	-10.0%
Q2 24	+31.3%	+1.7%
Q3 24	+23.4%	-2.7%
Q4 24	+32.0%	-93.7%
Q1 25	+17.5%	+7.3%
Q2 25	-6.1%	-1.8%
Q3 25	+20.7%	+5.0%
Q4 25	+25.2%	+861.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$14M	17.8%
Q2 23	$13M	18.1%
Q3 23	$13M	18.9%
Q4 23	$10M	15.2%
Q1 24	$13M	18.5%
Q2 24	$16M	17.8%
Q3 24	$7M	8.7%
Q4 24	$26M	30.3%
Q1 25	$9M	10.5%
Q2 25	$9M	10.9%
Q3 25	$8M	8.4%
Q4 25	$8M	7.5%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$24M	$28M	$23M
Q2 23	$20M	$29M	$22M
Q3 23	$19M	$34M	$18M
Q4 23	$18M	$27M	$20M
Q1 24	$19M	$27M	$20M
Q2 24	$20M	$31M	$21M
Q3 24	$17M	$29M	$20M
Q4 24	$17M	$41M	$21M
Q1 25	$19M	$23M	$23M
Q2 25	$17M	$28M	$24M
Q3 25	$17M	$28M	$24M
Q4 25	$19M	$29M	$31M

Revenue Segments

Quarter

Revenue by Geography

Quarter	Europe	Rest Of The World	United States
Q3 23	$2M	$2M	$63M
Q1 24	$2M	$1M	$69M
Q2 24	$3M	$1M	$88M
Q3 24	$3M	$1M	$79M
Q4 24	$3M	$1M	$82M
Q1 25	—	$5M	$80M
Q2 25	—	$5M	$82M
Q3 25	—	$5M	$95M
Q4 25	—	—	$103M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$75M	$211M	$286M
Q2 23	$88M	$195M	$283M
Q3 23	$76M	$192M	$268M
Q4 23	$82M	$153M	$235M
Q1 24	$93M	$123M	$216M
Q2 24	$96M	$133M	$229M
Q3 24	$95M	$145M	$241M
Q4 24	$115M	$146M	$261M
Q1 25	$89M	$142M	$231M
Q2 25	$68M	$118M	$186M
Q3 25	$91M	$103M	$194M
Q4 25	$65M	$112M	$177M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	54M	+0.2%
Q2 23	54M	+0.4%
Q3 23	54M	+0.6%
Q4 23	53M	-2.7%
Q1 24	52M	-2.0%
Q2 24	52M	+1.0%
Q3 24	53M	+1.4%
Q4 24	58M	+10.1%
Q1 25	55M	-5.1%
Q2 25	54M	-1.7%
Q3 25	54M	-1.0%
Q4 25	51M	-4.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$402K	68
FY 15	$296K	95
FY 16	$5M	8
FY 17	$270K	179
FY 18	$331K	231
FY 19	$329K	386
FY 20	$405K	475
FY 21	$460K	645
FY 22	$436K	738
FY 23	$436K	643
FY 24	$514K	650
FY 25	$496K	765